Itoprom

Itopride Hydrochloride, the active ingredient in Itoprom, is a prokinetic agent presented as an oral dosage form for oral administration. It is indicated for functional gastrointestinal disorders, including functional dyspepsia, gastric motility disorders, and gastroesophageal reflux disease, primarily in adult patients. The product complies with EU regulatory standards and is available for export to multiple markets. It is manufactured under GMP conditions and undergoes rigorous quality testing before distribution.

GNH USA supplies Itoprom as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Itopride Hydrochloride is a prokinetic agent used to improve gastrointestinal motility in functional gastrointestinal disorders. - Functional dyspepsia: alleviates upper abdominal discomfort and early satiety by enhancing gastric emptying. - Gastric motility disorders: improves gastric emptying and reduces stasis in conditions such as gastroparesis. - Gastroesophageal reflux disease: reduces reflux episodes by promoting coordinated esophageal clearance.

Adverse reactions to Itopride Hydrochloride are generally mild but may vary among individuals.

Common Side Effects: - Nausea: mild transient feeling of queasiness. - Diarrhea: loose stools occurring intermittently. - Abdominal pain: cramp-like discomfort in the stomach area. - Headache: mild to moderate head pain. - Dizziness: sensation of light‑headedness or unsteadiness. - Dry mouth: reduced salivation causing throat dryness. - Fatigue: feeling of tiredness or lack of energy.

Serious or Rare Side Effects: - Extrapyramidal symptoms: involuntary muscle movements or rigidity. - Allergic reactions: rash, itching, or swelling indicating hypersensitivity. - Hepatotoxicity: signs of liver injury such as jaundice. - Cardiac arrhythmia: irregular heart rhythm reported rarely. - Severe hypotension: marked drop in blood pressure. - Pancreatitis: inflammation of the pancreas presenting with abdominal pain. - Seizures: rare occurrence of convulsive episodes.

When prescribing Itopride Hydrochloride, clinicians should consider several precautionary measures to ensure safe use. - Pregnancy: use only if potential benefit justifies the risk, as safety data are limited. - Breastfeeding: assess risk versus benefit because excretion in milk is not well established. - Renal impairment: adjust therapy or monitor closely in patients with reduced kidney function. - Hepatic impairment: use with caution in patients with liver disease. - Drug interactions: review concomitant medications that may affect dopamine or acetylcholine pathways. - Store at ambient temperature: keep below 25 °C, protect from moisture and light in the original packaging.

Itopride Hydrochloride may interact with other medicines that influence dopaminergic or cholinergic activity, as well as drugs affecting gastrointestinal motility.

Major Interactions (Avoid): - Antipsychotics (e.g., haloperidol): may counteract prokinetic effect. - Anticholinergic agents (e.g., atropine): may diminish efficacy. - CYP450 inhibitors (e.g., ketoconazole): potential increase in plasma levels.

Moderate Interactions (Monitor Closely): - Metoclopramide: additive prokinetic action may increase risk of extrapyramidal symptoms. - MAO inhibitors: possible enhanced dopaminergic effects. - Proton pump inhibitors: may alter gastric pH influencing drug absorption.